CLC bio, a QIAGEN Company, has announced a new release of CLC Drug Discovery Workbench, an enterprise drug-design platform for medicinal and computational scientists
CLC bio has released an add-on module to CLC Genomics Workbench, which has been developed to help finish the assembly of small genomes
Version 5.5 of Molegro Virtual Docker, an integrated platform for computational drug design available for Windows, Linux and Mac OS X, has been released by CLC bio
CLC bio has released version 5.5 of its CLC Genomics Workbench desktop software, supporting a complete resequencing workflow from read mapping over variant detection to downstream analysis
CLC bio has incorporated the features from its CLC DNA Workbench, CLC RNA Workbench and CLC Protein Workbench desktop software packages into a single commercial workbench
CLC bio has revealed Genomics Gateway, a new framework for visualising, combining and analysing genome data
CLC bio has released version 2.0 of CLC Genomics Server, its enterprise platform for Next Generation Sequencing data analysis
CLC bio has released new versions of its solutions for analysing and visualising next generation sequencing data: CLC Genomics Workbench, version 3.5, and CLC Genomics Server, version 1.5.
CLC bio has released Genomics Workbench version 3.0, for analysis and visualisation of sequencing data. The cross-platform software combines expression analyses with next-generation sequencing, bridging analogue and digital gene expression
CLC bio has released its Next Generation Sequencing (NGS) solution, CLC Genomics Workbench, which incorporates cutting-edge technology and algorithms, while also supporting and integrating with the rest of a typical NGS workflow.
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
